Acadian Asset Management LLC Reduces Holdings in Lifevantage Corporation $LFVN

Acadian Asset Management LLC lowered its stake in shares of Lifevantage Corporation (NASDAQ:LFVN) by 23.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 224,030 shares of the company’s stock after selling 67,670 shares during the quarter. Acadian Asset Management LLC owned about 1.78% of Lifevantage worth $2,927,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of LFVN. Farther Finance Advisors LLC bought a new stake in Lifevantage during the 2nd quarter valued at approximately $25,000. Cubist Systematic Strategies LLC bought a new stake in shares of Lifevantage during the first quarter valued at approximately $97,000. AlphaQuest LLC boosted its position in shares of Lifevantage by 12,659.7% during the second quarter. AlphaQuest LLC now owns 7,911 shares of the company’s stock valued at $103,000 after purchasing an additional 7,849 shares in the last quarter. State of Wyoming purchased a new stake in Lifevantage in the first quarter worth $173,000. Finally, XTX Topco Ltd bought a new position in Lifevantage in the first quarter worth $186,000. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Weiss Ratings restated a “hold (c+)” rating on shares of Lifevantage in a report on Wednesday, October 8th. Lake Street Capital reissued a “buy” rating and set a $12.00 price target on shares of Lifevantage in a research report on Wednesday, November 5th. Finally, Wall Street Zen cut shares of Lifevantage from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $23.50.

Insider Activity at Lifevantage

In other news, Director Michael A. Beindorff sold 35,000 shares of Lifevantage stock in a transaction that occurred on Friday, November 7th. The shares were sold at an average price of $6.92, for a total value of $242,200.00. Following the completion of the sale, the director directly owned 56,413 shares in the company, valued at $390,377.96. The trade was a 38.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders have sold 40,325 shares of company stock valued at $298,990 in the last three months. Insiders own 21.95% of the company’s stock.

Lifevantage Trading Up 2.3%

Lifevantage stock opened at $6.62 on Friday. Lifevantage Corporation has a 12 month low of $6.38 and a 12 month high of $27.38. The stock has a fifty day simple moving average of $9.12 and a two-hundred day simple moving average of $11.55. The firm has a market cap of $84.08 million, a price-to-earnings ratio of 8.95 and a beta of 0.22.

Lifevantage (NASDAQ:LFVN) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Lifevantage had a return on equity of 33.75% and a net margin of 4.29%.The firm had revenue of $47.56 million for the quarter, compared to the consensus estimate of $54.74 million. Lifevantage has set its FY 2026 guidance at 1.000-1.150 EPS.

Lifevantage Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Monday, December 1st will be issued a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Monday, December 1st. Lifevantage’s dividend payout ratio (DPR) is presently 23.38%.

Lifevantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.